Cyberattack on UK Health Firm Contributed to Patient Death
A cyberattack that caused disruption at hospitals in London last year contributed to the death of a patient, health officials have confirmed for the first time.
The incident occurred after a Russian hacking gang in June 2024 targeted Synnovis, a contractor that provides blood testing, transfusion and other pathology services to the UK's National Health Service, or NHS. The breach triggered a major crisis at health-care providers predominantly in the southeast of the city.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
WIRED
an hour ago
- WIRED
'They're Not Breathing': Inside the Chaos of ICE Detention Center 911 Calls
On April 28, a nurse at the Aurora ICE Processing Center near Denver called 911. A woman in custody, four months pregnant, had arrived at the facility's medical unit, bleeding and in pain. As the staff rushed to get vitals, the dispatcher rattled off questions: How old was she? Was the pregnancy high risk? The nurse hesitated: 'She just came to us three days ago.' WIRED has made this article free for all to read because it is primarily based on reporting from Freedom of Information Act requests. Please consider subscribing to support our journalism. On 911 audio obtained by WIRED, the dispatcher's voice cuts in: 'Is there any sign of life?' 'Have we heard a heartbeat?' 'Does she feel any kicking?' 'We don't have the equipment to do that,' the nurse replies. It was just one incident in a spike of emergencies playing out inside Immigration and Customs Enforcement detention centers nationwide. A WIRED investigation into 911 calls from 10 of the nation's largest immigration detention centers found that serious medical incidents are rising at many of the sites. The data, obtained through public records requests, show that at least 60 percent of the centers analyzed had reported serious pregnancy complications, suicide attempts, or sexual assault allegations. Since January, these 10 facilities have collectively placed nearly 400 emergency calls. Nearly 50 of those have involved potential cardiac episodes, 26 referenced seizures, and 17 reported head injuries. Seven calls described suicide attempts or self-harm, including overdoses and hangings. Six others involved allegations of sexual abuse—including at least one case logged as 'staff on detainee.' WIRED spoke with immigration attorneys, local migrant advocates, national policy experts, and individuals who have been recently detained or have family currently in ICE custody. Their accounts echoed the data: a system overwhelmed, and at times, seemingly indifferent to medical crises.
Fox News
2 hours ago
- Fox News
Planned Parenthood encourages 'men' to get cervical cancer screening for Men's Health Month
A Planned Parenthood affiliate went viral on social media after it encouraged "trans men" to get cervical cancer screenings for Men's Health Month. On Sunday, Planned Parenthood of Southern New England recognized Men's Health Month with a Facebook post urging transgender men, who are biologically women, to get the important health screening. "It's Men's Health Month, and that means highlighting the health needs of ALL men," the post read. "Trans men are men and need cervical cancer screenings, too." The cervix is an organ in the female reproductive system that connects the uterus to the vagina. Adult women are recommended to get cervical cancer screenings every three years. The Planned Parenthood post also gave tips for how transgender men can make these intimate exams "more comfortable." Accompanying the post was a drawing of a transgender character, topless with mastectomy scars on the person's breasts. The post drew over 70,000 reactions on the Facebook post alone. The organization turned off the comments but nearly 63,000 people who reacted "laughed" at the post. Planned Parenthood's press office did not return Fox News Digital's request for comment. OutKick flagged the post and asked Planned Parenthood if it 'believes that 'trans men are men' and, if 'trans men are men,' why do they need cervical cancer screenings since only women have cervices?" A recent report by a conservative watchdog claimed Planned Parenthood manipulates the definition of contraception in order to provide transgender hormone therapy to minors without parental consent. "Using contraception as a 'gender-affirming' treatment is a massive loophole," the American Principles Project report stated. "Most states allow minors to consent to these contraceptives on their own, and many states allow minors to do so without even notifying parents." Planned Parenthood pushed back on the report and denied it was violating the law. "We strongly denounce the dangerous spread of disinformation about life-saving gender-affirming healthcare that is fueled by rampant transphobia," Planned Parenthood of the Pacific Southwest's President and CEO, Jenny Black, previously told Fox News Digital. "We will continue to provide safe and legal health care to those who rely on us for access to quality and compassionate care." Planned Parenthood affiliates received nearly $800 million in government reimbursements and grants during a one-year span, according to the organization's 2023-2024 annual report. In March, the Trump administration notified Planned Parenthood affiliates across the nation that it was withholding tens of millions of dollars of federal funding due to possible violations of Trump's executive orders – such as the banning of diversity, equity and inclusion (DEI) programs – and federal civil rights laws.
Medscape
2 hours ago
- Medscape
Fast Five Quiz: Risk Factors, Symptoms, & Treatments for AD
Alzheimer's disease is the most common form of dementia. Researchers believe that converging environmental, lifestyle, and genetic risk factors trigger a pathophysiologic cascade that, over decades, leads to Alzheimer's pathology and dementia. Depending on such risk factors and related symptoms, certain treatments can be utilized to help manage and slow disease progression. Do you know the risk factors, symptoms, and potential treatments for Alzheimer's disease? Test your knowledge with this quick quiz. Midlife hypertension is an established risk factor for Alzheimer-type dementia. Further, a brain autopsy study evaluating the link between hypertension and Alzheimer's disease found that patients using beta-blockers to control blood pressure had fewer Alzheimer-type brain lesions on autopsy compared with patients taking no drug therapy. Other risk factors for Alzheimer-type dementia include: Advancing age Family history APOE4 genotype genotype Obesity Insulin resistance Vascular factors Dyslipidemia Inflammatory markers Down syndrome Traumatic brain injury Caffeine is generally not a recognized risk factor for Alzheimer-type dementia or Alzheimer's disease. In fact, some studies have demonstrated a lower incidence of Alzheimer's disease in patients who consume caffeinated coffee. Similarly, moderate alcohol consumption is generally not recognized as a risk factor. In the 1960s and 1970s, exposure to aluminum was thought to be a possible risk factor for the development of Alzheimer's disease, leading to concerns about the use of cookware, antiperspirants, foil, antacids, and beverage cans in everyday life. Although studies have shown the neurotoxic effects of aluminum, particularly via exposure through dietary sources, they have failed to confirm a direct correlation between aluminum exposure and the development of Alzheimer's disease. Learn more about the risk factors for Alzheimer's disease. A 2025 report from the Alzheimer's Association indicated that older Black males and females are twice as likely to develop dementias, including Alzheimer's disease, compared with older White patients. Further, the same report noted that older Hispanic patients are at an increased risk for dementia and Alzheimer's disease when compared with older White, non-Hispanic patients. Specifically, the report states this population is 'one and one-half times as likely to have Alzheimer's or other dementias as White older adults.' Modifiable health factors include midlife obesity, which has been associated with the largest proportion of Alzheimer's disease cases in Black individuals, as well as physical inactivity. Additionally, cardiovascular and metabolic conditions, all of which elevate risk for dementia, disproportionately affect this demographic. Socioeconomic and psychosocial factors that correlate with dementia risk among older Black individuals include limited access to education, financial stability, and marital status. Missed and delayed diagnoses are more common in Black communities, and cultural bias in screening tools often leads to under-detection. Learn more about the epidemiology of Alzheimer's disease. By the time Alzheimer's disease reaches the moderate stage, damage has spread further to the areas of the cerebral cortex that control language, reasoning, sensory processing, and conscious thought. Affected regions continue to atrophy, making signs and symptoms of the disease more prominent, particularly as they relate to memory, judgment, and impulse control. The symptoms of this stage are typically: Increasing memory loss and confusion Shortened attention span Problems recognizing friends and family members Difficulty with language; problems with reading, writing, and working with numbers Difficulty organizing thoughts and thinking logically Inability to learn new things or to cope with new or unexpected situations Restlessness, agitation, anxiety, tearfulness, and wandering, especially in the late afternoon or at night Repetitive statements or movement, and occasional muscle twitches Hallucinations, delusions, suspiciousness or paranoia, and irritability Loss of impulse control (shown through such behavior as undressing at inappropriate times or places or using vulgar language) Perceptual motor problems (such as trouble getting out of a chair or setting the table) Pyramidal tract lesions, also known as upper motor neuron lesions, cause a wide range of motor deficits, including hyperactive reflexes, a positive Babinski sign (toe extension when stroking the sole of the foot), and spasticity. These can occur from any damage to the brain or spinal cord as a result of a stroke, trauma, tumors, meningitis, multiple sclerosis, or neurodegenerative disease, such as amyotrophic lateral sclerosis. While these lesions do occasionally occur in patients with Alzheimer's disease, their appearance is uncommon in this patient population. Hypothyroidism and hyperthyroidism can affect cognitive function and should be assessed during the initial workup for Alzheimer's disease. Although it is possible for either one to co-occur in patients, neither is a common symptom of moderate-stage disease. Seizures are not a common symptom associated with moderate Alzheimer's disease but are possible, particularly in late-stage disease and are potentially owing to poor disease course. Learn more about the clinical presentation of Alzheimer's disease. Structural neuroimaging with MRI (or noncontrast CT) to detect lesions that might cause cognitive impairment (eg, stroke, small vessel disease, and tumor) is typically most appropriate during the initial evaluation of patients with dementia or Alzheimer's disease. Imaging studies are part of initial diagnosis and are particularly important to assess for and rule out potentially treatable causes of progressive cognitive decline, such as chronic subdural hematoma or normal pressure hydrocephalus. Brain scanning with single-photon emission CT or PET is usually not recommended for the workup of patients with typical presentations of Alzheimer's disease. EEG is also not generally recommended but is valuable when Creutzfeldt-Jakob disease or another prion-related disease is a likely diagnosis. However, imaging studies are no longer the only method used in the initial evaluation of patients suspected of having Alzheimer's disease. In May 2025, the FDA approved the use of the Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio for the early detection of amyloid plaques associated with Alzheimer's disease in adult patients, aged 55 years and older, who are exhibiting signs and symptoms of the disease. Although not intended as a stand-alone diagnostic test, it serves as an additional resource to clinicians in a specialized setting as a less invasive diagnostic option. The test increases diagnostic accessibility to patients who might not have easy access to imaging. Learn more about the workup of Alzheimer's disease. Early detection combined with timely treatment enables patients with Alzheimer's disease to preserve their cognition and functional capacities at optimal levels. Cholinesterase inhibitors, along with mental exercises, are prescribed to help prevent or delay the deterioration of cognition in patients with Alzheimer's disease. Cholinesterase inhibitors that have been approved in the US and Europe for the treatment of Alzheimer's disease include donepezil, galantamine, and rivastigmine. Further, certain antiamyloid monoclonal antibody treatments have been approved to slow disease progression as well. According to the Alzheimer's Association, nonpharmacological treatments used to initially and routinely manage symptoms include 'physical activity, reminiscence exercises, music ‐ and art ‐ based therapies, pet therapy, and light therapy.' Some studies suggest that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) might have a protective effect against Alzheimer's disease, potentially through their anti-inflammatory effects and possible ability to reduce amyloid. However, findings from observational studies and short-term randomized controlled trials have been mixed, and optimal dosage and duration of (NSAIDs) for this purpose remain unclear. Studies suggest that long-term (but not cumulative) use of NSAIDs might be associated with decreased dementia risk. However, further investigation is warranted. Neuroleptic agents are not generally used to prevent or delay deterioration of cognition in patients with Alzheimer's disease. Some data have indicated that they are linked to an increased risk of cognitive decline. While some studies have shown that vitamin E can reduce amyloid-beta oxidative stress, as well as improve memory and cognitive deficits, conflicting results were noted in clinical trials assessing the efficacy of vitamin E as a preventive or treatment for Alzheimer's disease. Further, they are not typically used as an initial therapy to prevent or delay deterioration of cognition in patients with Alzheimer's disease. Learn more about the treatment and management of Alzheimer's disease.
